Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Receivables - Doubtful (2018 - 2025)

Historic Receivables - Doubtful for Exponent (EXPO) over the last 8 years, with Q4 2025 value amounting to $7.6 million.

  • Exponent's Receivables - Doubtful rose 1765.16% to $7.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.6 million, marking a year-over-year increase of 1765.16%. This contributed to the annual value of $6.1 million for FY2025, which is 1628.48% up from last year.
  • Exponent's Receivables - Doubtful amounted to $7.6 million in Q4 2025, which was up 1765.16% from $6.2 million recorded in Q3 2025.
  • Over the past 5 years, Exponent's Receivables - Doubtful peaked at $7.6 million during Q4 2025, and registered a low of $4.0 million during Q1 2021.
  • Moreover, its 5-year median value for Receivables - Doubtful was $6.1 million (2022), whereas its average is $5.8 million.
  • As far as peak fluctuations go, Exponent's Receivables - Doubtful crashed by 2763.24% in 2021, and later soared by 4429.48% in 2023.
  • Quarter analysis of 5 years shows Exponent's Receivables - Doubtful stood at $4.4 million in 2021, then skyrocketed by 40.02% to $6.2 million in 2022, then fell by 14.73% to $5.3 million in 2023, then increased by 22.72% to $6.5 million in 2024, then increased by 17.65% to $7.6 million in 2025.
  • Its Receivables - Doubtful stands at $7.6 million for Q4 2025, versus $6.2 million for Q3 2025 and $6.3 million for Q2 2025.